৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
As an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, Apolipoprotein B (Apo-B), and triglycerides when response to diet and other non‑pharmacological measures is inadequate.
To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolemia.
To reduce elevated cholesterol and triglycerides in patients with mixed dyslipidemia (Fredrickson Type IIa and IIb).
For treatment of patients with elevated serum triglycerides in hypertriglyceridemia (Fredrickson Type IV).
For treatment of patients with diabetic dyslipoproteinemia (Fredrickson Type III).
To reduce cardiac ischemic events in patients with asymptomatic or mild to moderate symptomatic coronary artery disease with elevated LDL cholesterol.
To reduce total and LDL cholesterol concentrations in patients with hypercholesterolemia associated with organ transplantation (renal or other).
Atorvastatin is a selective inhibitor of HMG‑CoA reductase, the rate‑limiting enzyme responsible for conversion of HMG‑CoA to mevalonate, a precursor of sterols including cholesterol.
Absorption: Rapid after oral administration; peak plasma concentration within 1–2 hours. Bioavailability ~14%.
Distribution: Volume of distribution ~38 L; 95% bound to plasma proteins.
Metabolism: Extensively metabolized by CYP3A4 to active metabolites.
Excretion: Primarily via bile; half‑life ~14 hours, inhibitory activity 20–30 hours.
Primary hypercholesterolemia/mixed hyperlipidemia: Adults: 10 mg once daily, titrated up to 80 mg. Children (10–17 years): 10 mg once daily, max 20 mg.
Familial hypercholesterolemia: Adults: 10 mg daily, titrated up to 80 mg. Children (10–17 years): 10 mg daily, max 20 mg.
Prevention of cardiovascular events: Adults: 10–20 mg daily, titrated as needed.
Increased risk of myopathy with cyclosporine, fibrates, niacin, erythromycin, antifungals.
Antacids reduce plasma concentration (~35%) but not LDL‑C reduction.
Colestipol reduces plasma concentration (~25%) but enhances LDL‑C reduction.
Digoxin plasma concentration increases ~20%.
Oral contraceptives increase norethindrone and ethinyl estradiol levels.
Warfarin: No significant effect.
Hypersensitivity to components.
Active liver disease or unexplained persistent elevation of transaminases.
History of serious reaction to HMG‑CoA reductase inhibitors.
Common: Constipation, flatulence, dyspepsia, abdominal pain.
Others: Headache, back pain, rash, allergic reactions, arthralgia, myalgia.
Pregnancy: Contraindicated. May cause fetal toxicity; discontinue during pregnancy.
Lactation: Contraindicated. Unknown if excreted in human milk; potential for serious adverse reactions.
Drug Class: Statins (HMG-CoA reductase inhibitors)
Purpose:
Lowers LDL cholesterol (“bad cholesterol”)
Raises HDL cholesterol (“good cholesterol”)
Reduces triglycerides
Prevents cardiovascular events (heart attack, stroke, angina)
Dosage Forms: Tablets (10 mg, 20 mg, 40 mg, 80 mg) and oral suspension.
Common Brand Names: Lipitor, Atorvaliq.
Approval: First FDA-approved in 1996, now one of the most prescribed statins worldwide.
Indications of Atorvastatin
Atorvastatin is prescribed for:
Hypercholesterolemia: High cholesterol levels, especially elevated LDL (“bad cholesterol”).
Mixed dyslipidemia: Combination of high cholesterol and triglycerides.
Prevention of cardiovascular disease:
Reduces risk of heart attack, stroke, and angina in patients with risk factors (such as diabetes, hypertension, smoking, or family history).
Familial hypercholesterolemia: Genetic condition causing very high cholesterol.
Secondary prevention: For patients who already had a cardiovascular event (like heart attack or stroke) to prevent recurrence.




